Back

Title: Acetylcholine regulates pulmonary inflammation and facilitates the transition from active immunity to tissue repair during respiratory viral infection

Horkowitz, A. P.; Schwartz, A. V.; Alvarez, C. A.; Herrera, E. B.; Thoman, M. L.; Chatfield, D. A.; Osborn, K. G.; Feuer, R.; George, U. Z.; Phillips, J. A.

2020-07-02 immunology
10.1101/2020.07.02.184226 bioRxiv
Show abstract

ABSTRACTInflammatory control is critical to recovery from respiratory viral infection. Acetylcholine (ACh) secreted from non-neuronal sources, including lymphocytes, plays an important, albeit underappreciated, role in regulating immune-mediated inflammation. This study was designed to explore the role of ACh in acute viral infection and recovery. Using the murine model of influenza A, cholinergic status in the lungs and airway was examined over the course of infection and recovery. The results showed that airway ACh remained constant through the early stage of infection and increased during the peak of the acquired immune response. As the concentration of ACh increased, cholinergic lymphocytes appeared in the airway and lungs. Cholinergic capacity was found primarily in CD4 T cells, but also in B cells and CD8 T cells. The cholinergic CD4+ T cells bound to influenza-specific tetramers at the same frequency as their conventional (i.e., non-cholinergic) counterparts. In addition, they were retained in the lungs throughout the recovery phase and could still be detected in the resident memory regions of the lung up to two months after infection. Histologically, cholinergic lymphocytes were found in direct physical contact with activated macrophages throughout the lung. When ACh production was inhibited, mice exhibited increased tissue inflammation, altered lung architecture, and delayed recovery. Together, these findings point to a previously unrecognized role for ACh in the transition from active immunity to recovery and pulmonary repair following respiratory viral infection.View Full Text

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 14%
13.2%
2
Frontiers in Immunology
638 papers in training set
Top 0.8%
13.0%
3
American Journal of Physiology-Lung Cellular and Molecular Physiology
43 papers in training set
Top 0.1%
10.0%
4
ImmunoHorizons
24 papers in training set
Top 0.1%
8.1%
5
The Journal of Immunology
166 papers in training set
Top 0.5%
5.7%
6
Journal of Virology
499 papers in training set
Top 1%
5.7%
50% of probability mass above
7
PLOS Pathogens
820 papers in training set
Top 4%
3.3%
8
Microbiology Spectrum
469 papers in training set
Top 5%
2.8%
9
American Journal of Respiratory Cell and Molecular Biology
43 papers in training set
Top 0.3%
2.5%
10
mBio
833 papers in training set
Top 6%
2.4%
11
Infection and Immunity
120 papers in training set
Top 1.0%
2.2%
12
JCI Insight
277 papers in training set
Top 3%
2.2%
13
mSphere
302 papers in training set
Top 3%
1.9%
14
Scientific Reports
3612 papers in training set
Top 50%
1.9%
15
Communications Biology
993 papers in training set
Top 14%
1.7%
16
eLife
5828 papers in training set
Top 49%
1.7%
17
Virology
61 papers in training set
Top 0.7%
1.7%
18
The FASEB Journal
194 papers in training set
Top 3%
1.7%
19
Journal of Leukocyte Biology
42 papers in training set
Top 0.5%
1.4%
20
Immunology
28 papers in training set
Top 0.4%
1.2%
21
iScience
1154 papers in training set
Top 29%
1.1%
22
The Journal of Infectious Diseases
202 papers in training set
Top 4%
0.9%
23
Frontiers in Virology
15 papers in training set
Top 0.2%
0.9%
24
Mucosal Immunology
47 papers in training set
Top 1.0%
0.6%